CorEvitas® IBD Registry Launches Precision Medicine Program to Expand Treatment Insights & Advance Care

WALTHAM, Mass., Sept. 29, 2022 /PRNewswire/ -- CorEvitas, LLC, the leading sponsor of registries in autoimmune and inflammatory diseases, is pleased to announce its inflammatory bowel disease (IBD) registry sites are now actively collecting biospecimens from consented participants. This...